Lexicon Pharmaceuticals, Inc. (LXRX): Price and Financial Metrics
LXRX Price/Volume Stats
Current price | $0.78 | 52-week high | $3.73 |
Prev. close | $0.74 | 52-week low | $0.62 |
Day low | $0.75 | Volume | 2,598,400 |
Day high | $0.83 | Avg. volume | 4,857,170 |
50-day MA | $0.77 | Dividend yield | N/A |
200-day MA | $1.45 | Market Cap | 193.27M |
LXRX Stock Price Chart Interactive Chart >
Lexicon Pharmaceuticals, Inc. (LXRX) Company Bio
Lexicon Pharmaceuticals is a biopharmaceutical company focused on developing breakthrough treatments for human disease. Lexicon has clinical-stage drug programs for diabetes and carcinoid syndrome in progress. The company was founded in 1995 and is based in The Woodlands, Texas.
LXRX Price Returns
1-mo | 13.04% |
3-mo | -13.81% |
6-mo | -53.57% |
1-year | -75.47% |
3-year | -72.92% |
5-year | -72.92% |
YTD | 5.62% |
2024 | -51.73% |
2023 | -19.90% |
2022 | -51.52% |
2021 | 15.20% |
2020 | -17.59% |
Continue Researching LXRX
Want to do more research on Lexicon Pharmaceuticals Inc's stock and its price? Try the links below:Lexicon Pharmaceuticals Inc (LXRX) Stock Price | Nasdaq
Lexicon Pharmaceuticals Inc (LXRX) Stock Quote, History and News - Yahoo Finance
Lexicon Pharmaceuticals Inc (LXRX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...